Market Overview

5 Biotech Secondaries Traders Are Watching

Share:
Related
Mid-Afternoon Market Update: Ferroglobe Rises After Q1 Results; Great Basin Scientific Shares Drop
15 Biggest Mid-Day Gainers For Monday
Related VSAR
Benzinga's Top Upgrades, Downgrades For May 5, 2017
Benzinga's Top Upgrades, Downgrades For March 9, 2017

Below are five biotech companies looking to raise money this week.

Puma Biotechnology Inc (NYSE: PBYI) is offering 1 million shares of stock. The underwriters are Bank of America Merrill Lynch, J.P. Morgan, Leerink Partners, and Cowen. The deal is expected to price Wednesday night and trade Thursday.

Versartis Inc (NASDAQ: VSAR) is offering $75 million of stock. The underwriters are Citigroup, Credit Suisse, Cowen, Canaccord Genuity, and SunTrust Robinson Humphrey. The deal is expected to price Wednesday night and trade Thursday.

Zafgen Inc (NASDAQ: ZFGN) is offering 2,840,909 shares of stock. The underwriters are Leerink, Cowen, Canaccord, and JMP Securities. The deal is expected to price Thursday night and trade Friday.

The company is expected to report Phase 3 results of Beloranib for Prader-Willi Syndrome in the fourth quarter.

Related Link: 10 Biotech Stories You Might've Missed

Vitae Pharmaceuticals Inc (NASDAQ: VTAE) is offering 3 million shares of stock. The underwriters are Stifel, BMO Capital, Piper Jaffray, JMP Securities, and Wedbush. The deal is expected to price Thursday night and trade Friday.

The company is expecting to report Phase 2 data of VTP-34072 for Type 2 diabetes in the first half of 2015.

Verastem Inc (NASDAQ: VSTM) is offering $40 million worth of stock. The underwriters are Jefferies, Leerink Partners, Guggenheim, and Oppenheimer. The deal is expected to price Thursday night and trade Friday.

Verastem is expected to announce an interim analysis for its Phase II trial of VS-6063 for mesothelioma in the second quarter.

Posted-In: Long Ideas Previews FDA Trading Ideas

 

Related Articles (PBYI + VSAR)

View Comments and Join the Discussion!